Management of paediatric asthma

Area of Science:

• Pediatric Pulmonology
• Clinical Pharmacology

Background:

• Asthma management in children requires adherence to guidelines.
• Therapy reduction is crucial once asthma control is achieved.
• Pediatric asthma is heterogeneous, with variable responses to treatment.

Purpose of the Study:

• To outline best practices for pediatric asthma management.
• To emphasize individualized treatment approaches for young children.
• To discuss current and emerging therapeutic strategies.

Main Methods:

• Review of current pediatric asthma consensus guidelines.
• Analysis of treatment responses in preschool children and infants.
• Discussion of novel therapeutic agents and drug delivery systems.

Main Results:

• Optimal pediatric asthma care involves appropriate medication selection and de-escalation.
• Bronchodilators and inhaled corticosteroids may not be effective in all young children.
• Specific dosage limits for inhaled corticosteroids (200 microg beclometasone dipropionate equivalent BID) and avoidance of regular oral steroids or long-acting beta2-adrenoceptor agonists are recommended for infants and preschool children.

Conclusions:

• Best practice in pediatric asthma necessitates precise therapeutic choices and timely dose reduction.
• Clinicians must recognize the heterogeneity of asthma in young children and potential non-response to standard therapies.
• Future advancements may focus on convenient drug delivery and personalized prophylaxis rather than entirely new drug classes.